TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 333.0M
Gross Profit 109.8M 32.97%
Operating Income 1.6M 0.48%
Net Income 709.0K 0.21%
EPS (Diluted) $0.00

Balance Sheet Metrics

Total Assets 2.1B
Total Liabilities 647.6M
Shareholders Equity 1.5B
Debt to Equity 0.44

Cash Flow Metrics

Operating Cash Flow 23.3M
Free Cash Flow -10.3M

Revenue & Profitability Trend

Lifestance Health Income Statement From 2019 to 2024

Metric20242023202220212019
Revenue i1.3B1.1B859.5M667.5M212.5M
Cost of Goods Sold i848.6M753.6M622.5M466.0M150.1M
Gross Profit i402.4M302.1M237.0M201.5M62.4M
Gross Margin % i32.2%28.6%27.6%30.2%29.4%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i363.1M410.8M378.0M433.7M41.1M
Other Operating Expenses i-----
Total Operating Expenses i363.1M410.8M378.0M433.7M41.1M
Operating Income i-31.6M-189.1M-210.2M-286.4M15.2M
Operating Margin % i-2.5%-17.9%-24.5%-42.9%7.2%
Non-Operating Items
Interest Income i-----
Interest Expense i26.5M21.2M19.9M38.9M5.4M
Other Non-Operating Income535.0K3.8M-2.6M-7.8M-2.0M
Pre-tax Income i-57.6M-206.6M-232.7M-333.1M7.9M
Income Tax i-170.0K-20.3M-17.2M-25.9M2.2M
Effective Tax Rate % i0.0%0.0%0.0%0.0%28.0%
Net Income i-57.4M-186.3M-215.6M-307.2M5.7M
Net Margin % i-4.6%-17.6%-25.1%-46.0%2.7%
Key Metrics
EBITDA i39.0M-108.8M-141.2M-233.7M21.3M
EPS (Basic) i$-0.15$-0.51$-0.61$-1.05$-0.16
EPS (Diluted) i$-0.15$-0.51$-0.61$-1.05$-0.16
Basic Shares Outstanding i379147000367457000355278000327523000373648648
Diluted Shares Outstanding i379147000367457000355278000327523000373648648

Income Statement Trend

Lifestance Health Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i154.6M78.8M108.6M148.0M18.8M
Short-term Investments i-----
Accounts Receivable i131.8M125.4M100.9M76.1M43.7M
Inventory i-----
Other Current Assets14.9M10.7M11.0M11.7M810.0K
Total Current Assets i312.5M225.7M233.2M266.5M76.3M
Non-Current Assets
Property, Plant & Equipment i148.7M171.5M200.4M1.0M2.1M
Goodwill i2.8B2.8B2.8B2.7B2.5B
Intangible Assets i190.8M221.1M263.3M300.4M332.8M
Long-term Investments-----
Other Non-Current Assets7.7M10.9M10.8M3.4M-
Total Non-Current Assets i1.8B1.9B1.9B1.7B1.5B
Total Assets i2.1B2.1B2.2B1.9B1.6B
Liabilities
Current Liabilities
Accounts Payable i25.7M23.2M24.4M24.6M15.0M
Short-term Debt i56.7M46.5M38.8M1.3M3.7M
Current Portion of Long-term Debt-----
Other Current Liabilities542.0K11.9M18.8M14.8M11.8M
Total Current Liabilities i228.9M202.9M176.0M116.8M75.9M
Non-Current Liabilities
Long-term Debt i428.5M461.6M437.7M157.4M362.5M
Deferred Tax Liabilities i14.3M15.6M38.7M54.3M81.2M
Other Non-Current Liabilities309.0K952.0K2.8M53.6M17.2M
Total Non-Current Liabilities i443.1M478.2M479.1M265.3M461.0M
Total Liabilities i672.0M681.0M655.1M382.1M536.9M
Equity
Common Stock i3.8M3.8M3.8M3.7M1.0B
Retained Earnings i-818.3M-760.8M-572.6M-357.1M-13.1M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.4B1.4B1.5B1.5B1.0B
Key Metrics
Total Debt i485.2M508.1M476.5M158.7M366.3M
Working Capital i83.6M22.9M57.2M149.8M359.0K

Balance Sheet Composition

Lifestance Health Cash Flow Statement From 2019 to 2024

Metric20242023202220212019
Operating Activities
Net Income i-57.4M-186.3M-215.6M-307.2M5.7M
Depreciation & Amortization i71.0M80.4M69.2M54.1M6.1M
Stock-Based Compensation i76.2M99.4M187.4M259.4M54.0K
Working Capital Changes i-52.6M-67.3M-27.2M-23.6M-3.2M
Operating Cash Flow i77.0M-50.5M39.2M-30.8M10.8M
Investing Activities
Capital Expenditures i-21.6M-40.5M-79.3M-94.5M-14.3M
Acquisitions i0-19.8M-60.2M-99.6M-59.1M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-21.6M-60.3M-139.5M-194.1M-73.4M
Financing Activities
Share Repurchases i--000
Dividends Paid i-----
Debt Issuance i287.8M57.8M257.3M98.8M55.9M
Debt Repayment i-289.5M-2.5M-187.8M-311.4M-488.0K
Financing Cash Flow i-9.9M47.4M47.3M313.9M48.5M
Free Cash Flow i85.7M-57.4M-26.5M-85.1M2.7M
Net Change in Cash i45.4M-63.4M-53.0M89.0M-14.1M

Cash Flow Trend

Lifestance Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -37.00
Forward P/E -32.65
Price to Book 1.47
Price to Sales 1.64
PEG Ratio 0.44

Profitability Ratios

Profit Margin -1.23%
Operating Margin -0.85%
Return on Equity -1.11%
Return on Assets 0.04%

Financial Health

Current Ratio 1.48
Debt to Equity 32.18
Beta 1.13

Per Share Data

EPS (TTM) $-0.04
Book Value per Share $3.79
Revenue per Share $3.44

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
lfst2.2B-37.001.47-1.11%-1.23%32.18
HCA Healthcare 94.6B16.99-77.2513,631.68%8.21%-37.45
Tenet Healthcare 15.7B11.154.1829.65%7.18%158.70
DaVita 9.8B13.556.8657.94%6.35%825.19
Ensign Group 9.8B30.664.8017.54%7.00%100.93
Chemed 6.6B23.365.5024.14%11.56%12.15

Financial data is updated regularly. All figures are in the company's reporting currency.